Literature DB >> 1637730

Similar antiischemic effects of intracoronary atenolol and nifedipine during brief coronary occlusions in humans.

S Ghio1, S De Servi, L Angoli, E Bramucci, E Eleuteri, S Raffaghello, G Specchia.   

Abstract

To compare the antiischemic effects of intracoronary administration of a beta blocker, atenolol, and of a calcium antagonist, nifedipine, on the clinical and electrocardiographic signs of myocardial ischemia induced by balloon occlusion of the coronary artery, we studied 32 consecutive patients undergoing routine PTCA. In each patient at least three balloon inflations were performed: the first served to verify the occurrence of ischemia (ST segment depression/elevation greater than 1.5 mm); the second was used as a control occlusion; the third was performed after the patients were assigned to receive either atenolol 1.0 mg IC (group 1, N = 16) or nifedipine V = 0.2 mg IC (group 2, N = 16). In a control population of 10 patients, the time to return to baseline of the ECG tended to be progressively shorter during the three consecutive inflations, but the other clinical and ECG parameters did not change significantly. In group 1 and group 2, two patients did not show ECG signs of ischemia at the third inflation; the time to ischemia increased in group 1 (+76%, p less than .001) and group 2 (+85%, p less than .01; NS group 1 versus group 2); ST segment displacement at 30 seconds decreased in group 1 (-38%, p less than .01) and group 2 (-36%, p less than .01; NS group 1 versus group 2).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637730     DOI: 10.1007/bf00051147

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  16 in total

1.  Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction.

Authors:  F Waagstein; A C Hjalmarson
Journal:  Acta Med Scand Suppl       Date:  1976

2.  Effects of nitroglycerin and nifedipine on coronary and systemic hemodynamics during transient coronary artery occlusion.

Authors:  M J Kern; U Deligonul; A Labovitz; G Gabliani; M Vandormael; H L Kennedy
Journal:  Am Heart J       Date:  1988-06       Impact factor: 4.749

3.  Prolonged application of pressure in transluminal coronary angioplasty.

Authors:  M Kaltenbach; J Beyer; S Walter; H Klepzig; L Schmidts
Journal:  Cathet Cardiovasc Diagn       Date:  1984

4.  Regional cardioplegia and cardioprotection during transluminal angioplasty, which role for nifedipine?

Authors:  P W Serruys; M van den Brand; R W Brower; P G Hugenholtz
Journal:  Eur Heart J       Date:  1983-05       Impact factor: 29.983

5.  Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol.

Authors:  D R Ramsdale; E B Faragher; D H Bennett; C L Bray; C Ward; J M Cruickshank; S Yusuf; P Sleight
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

6.  Effect of nitroglycerin on coronary collateral flow and pressure during acute coronary occlusion.

Authors:  R L Feldman; M Joyal; C R Conti; C J Pepine
Journal:  Am J Cardiol       Date:  1984-11-01       Impact factor: 2.778

7.  Amelioration by nitroglycerin of left ventricular ischemia induced by percutaneous transluminal coronary angioplasty: assessment by hemodynamic variables and left ventriculography.

Authors:  A J Doorey; H C Mehmel; F X Schwarz; W Kübler
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

8.  Effect of metoprolol on chest pain in acute myocardial infarction.

Authors:  J Herlitz; A Hjalmarson; S Holmberg; K Pennert; K Swedberg; A Vedin; F Waagstein; A Waldenström; H Wedel; L Wilhelmsen
Journal:  Br Heart J       Date:  1984-04

9.  Regional cardioprotection by subselective intracoronary nifedipine is not due to enhanced collateral flow during coronary angioplasty.

Authors:  G Pop; P W Serruys; F Piscione; P J de Feyter; M van den Brand; T Huizer; J W de Jong; P G Hugenholtz
Journal:  Int J Cardiol       Date:  1987-07       Impact factor: 4.164

10.  Reduction of infarct size with the early use of timolol in acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1984-01-05       Impact factor: 91.245

View more
  1 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.